Parkinson’s disease is the second most common incurable neurodegenerative disorder after Alzheimer’s disease.
It is characterised by the accumulation of protein deposits in dopaminergic neurons (in charge of producing dopamine) in the form of amyloid fibres. These aggregates are formed mainly by the alpha-synuclein protein and in a very complex manner, which makes it complicated to identify molecules which could prevent or revert the process and the neurodegeneration associated with it.
A scientific collaboration led by researchers at the Institute of Biotechnology and Biomedicine (IBB) of the Universitat Autònoma de Barcelona has identified a molecule which halts and reverts this neurodegeneration. After analysing over 14,000 molecules, they found the SynuClean-D molecule, which inhibits the aggregation of the alpha-synuclein protein and breaks the already formed amyloid fibres, thus preventing the initiation of the process causing the onset of the neurodegenerative Parkinson’s disease.
Through experiments conducted with the small Caenorhabditis elegans worm, one of the most commonly used animal models in neurodegenerative diseases, researchers were able to verify that by administering it through food, the molecule was capable of notably reducing alpha-synuclein aggregations, preventing the spread of toxic aggregates and therefore avoiding the degeneration of dopaminergic neurons.
“Everything seems to indicate that the molecule we identified, the SynuClean-D, may provide therapeutic applications for the treatment of neurodegenerative disases such as Parkinson’s in the future”, UAB researcher and coordinator of the study Salvador Ventura points out.
To identify SynuClean-D researchers developed a methodology capable of indentifying the alpha-synuclein aggregation inhibitors among thousands of molecules. Once identified, an in vitro biophysical characterisation was conducted of their inhibiting activity and tests were run to discover their behaviour with human neural cell cultures, before testing it in animal models of the disease (the Caenorhabditis elegans worm). These animals express the alpha-synuclein in the muscle or in dopaminergic neurons. The experiments demonstrated that the administration of the identified inhibitor reduced protein aggregation, improving the mobility of the animal and protecting it from neural degeneration.
The Latest on: Parkinson’s
via Google News
The Latest on: Parkinson’s
- Parkinson’s Foundation awards grant to Tech Parkinson Resource Centeron August 1, 2022 at 7:54 am
The Parkinson’s Foundation recently announced the recipients of more than $2 million in community grants for Parkinson’s disease (PD) programs across the U.S., including $12,000 for Louisiana Tech’s ...
- Are occasionally shaky hands a sign of Parkinson's disease?on August 1, 2022 at 7:10 am
DPA If your hands sometimes shake, should you be worried it's a sign of Parkinson's disease? Not necessarily, as hand tremors can have many causes. Laura Ludwig/dpa . Trembling ...
- ‘First-ever’ legislation to end Parkinson’s disease introduced in Houseon July 31, 2022 at 9:08 pm
A bipartisan bill that the Michael J. Fox Foundation for Parkinson’s Research is calling “the first-ever legislation solely devoted to ending Parkinson’s disease” has been introduced in the House of ...
- Nanobody treatment could help clear brain protein clumps in Parkinson'son July 31, 2022 at 8:49 pm
Clumps of misfolded proteins that gather in the brain have been linked to neurodegenerative diseases like Parkinson’s. Now, newly identified nanobodies show promise in destabilizing the structure of ...
- Wai Law finishes running around Long Island for Parkinson'son July 31, 2022 at 6:40 pm
The Bethpage resident completed seven days of running around Long Island at Stony Brook on Sunday, to raise money for Parkinson's research. His overall route was divided into two legs.
- Runner finishes circling LI to raise money to fight Parkinson'son July 31, 2022 at 4:12 pm
"Running is my passion," said Wai Law, an accountant from Bethpage. "If along the way I can use it to promote something good, that's a gift." ...
- Survey: Telehealth Improves Access to Parkinson's Careon July 29, 2022 at 5:40 am
Parkinson's Foundation survey says vast majority find greater access to remote care via NeuroSphere Virtual Clinic.
- Investigational Parkinson’s drug decreases side effectson July 29, 2022 at 2:22 am
With a solid pool game and a smooth golf swing, you would have never thought 70-year-old Wayne Holt has been living with Parkinson’s disease for 21 years. “I used to be a racquetball player and I ...
- Fighting back against Parkinson’s: Rock Steady Boxingon July 29, 2022 at 1:16 am
Those with Parkinson's Disease are rolling with the punches at Rock Steady Boxing fighting back against their diagnosis.
via Bing News